Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial–mesenchymal transition

被引：0
|
作者：
Steven H Lin
Jing Wang
Pierre Saintigny
Chia-Chin Wu
Uma Giri
Jing Zhang
Toshi Menju
Lixia Diao
Lauren Byers
John N Weinstein
Kevin R Coombes
Luc Girard
Ritsuko Komaki
Ignacio I Wistuba
Hiroshi Date
John D Minna
John V Heymach
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Bioinformatics and Computational Biology
[3] Cancer Research Center of Lyon,Department of Genomic Medicine
[4] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology
[5] The University of Texas MD Anderson Cancer Center,Hamon Center for Therapeutic Oncology
[6] Ohio State University College of Medicine,Department of Pathology
[7] The University of Texas Southwestern Medical Center,Department of Thoracic Surgery
[8] The University of Texas MD Anderson Cancer Center,undefined
[9] Kyoto University Hospital,undefined
来源：
BMC Genomics | / 15卷
关键词：
DNA methylation; Epithelial-mesenchymal transition; Erlotinib; Lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Thrombomodulin regulates doxorubicin sensitivity through epithelial-mesenchymal transition in non-small cell lung cancer
    Yang, Y.
    Cheng, B. -J.
    Lu, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 95 - 101
  • [42] EPITHELIAL MESENCHYMAL TRANSITION (EMT) AND NON-SMALL CELL LUNG CANCER (NSCLC): A MUTUAL ASSOCIATION WITH AIRWAY DISEASE
    Mahmood, M.
    Ward, C.
    Muller, H.
    Sohal, S.
    Walters, E.
    RESPIROLOGY, 2018, 23 : 96 - 96
  • [43] Epithelial to mesenchymal transition phenotype correlates with clinicopathological features and brain metastases in non-small cell lung cancer
    Prudkin, Ludmila
    Liu, Diane D.
    Sun, Menghong
    Ozburn, Natalie C.
    Brown, Kathlynn C.
    Bekele, B. Nebiyou
    Moran, Cesar
    Wistuba, Ignacio I.
    VIRCHOWS ARCHIV, 2008, 452 : S52 - S52
  • [44] An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer
    Richard J. Lobb
    Kekoolani S. Visan
    Li-Ying Wu
    Emma L. Norris
    Marcus L. Hastie
    Sarah Everitt
    Ian A. Yang
    Rayleen V. Bowman
    Shankar Siva
    Jill E. Larsen
    Jeffrey J. Gorman
    Michael MacManus
    Antoine Leimgruber
    Kwun M. Fong
    Andreas Möller
    Communications Biology, 6
  • [45] Mechanism of epithelial-mesenchymal transition inhibited by miR-203 in non-small cell lung cancer
    Huang, Weicong
    Wu, Yuanbo
    Cheng, Dezhi
    He, Zhifeng
    ONCOLOGY REPORTS, 2020, 43 (02) : 437 - 446
  • [46] Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells
    Ruan, Junshan
    Zhang, Lei
    Yan, Linggeng
    Liu, Yuping
    Yue, Zhiqiang
    Chen, Li
    Wang, Ai-Yun
    Chen, Wenxing
    Zheng, Shizhong
    Wang, Shaoming
    Lu, Yin
    MOLECULAR MEDICINE REPORTS, 2012, 6 (01) : 232 - 238
  • [47] FIBROBLAST INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) IN A NOVEL NON-SMALL CELL LUNG CANCER (NSCLC) MODEL
    Amann, A.
    Zwierzina, M.
    Bitsche, M.
    Gamerith, G.
    Huber, J.
    Koeck, S.
    Kelm, J.
    Hilbe, W.
    Zwierzina, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 543 - 543
  • [48] Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer
    Fujiwara, Ayako
    Shintani, Yasushi
    Funaki, Soichiro
    Kawamura, Tomohiro
    Kimura, Toru
    Minami, Masato
    Okumura, Meinoshin
    LUNG CANCER, 2017, 106 : 8 - 16
  • [49] ACCURATE ESTIMATION OF DNA METHYLATION FREQUENCY IN NON-SMALL CELL LUNG CANCER
    Do, Hongdo
    Mitchell, Paul
    John, Thomas
    Dobrovic, Alexander
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1048 - S1049
  • [50] Hsa_circ_0102899 promotes epithelial-mesenchymal transition in non-small cell lung cancer
    Wang, YanFei
    He, JieMing
    Liang, YongXue
    Xiong, DaLin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (11): : 3252 - 3262
12345